μFR® (Angio Based FFR)
UFR (IVUS based FFR)
OFR (OCT based FFR)
CT-QFR (CCTA based FFR)
Congratulations on the #12th International Course on Coronary Computational Physiology came to a successful conclusion. #μFR
July 1, 2022
#Global Computational Coronary Physiology Training Center # Fuwai Hospital, #CAMS&PUMC #Pulse...
Pulse's μFR Improved Clinical Outcomes and Saved Costs Over 1 Year in FAVOR III China Trial
May 28, 2022
Follow us at LinkedIn: Pulse Medical and Twitter: @PulseMedTech Quantitative flow ratio ...
Join us in Paris for #EuroPCR 2022
May 10, 2022
Join the "Pulse Medical Scientific Programe" to learn the progress of μFR, the evidence-based new...
OFR was approved by China FDA (NMPA)
December 2, 2021
Image from NMPA official website November 10th 2021, News from Shanghai, China. China...
LANCET: Pulse μFR guided PCI resulted in a 35% reduction of MACE at one year follow-up
November 5, 2021
On November 4, 2021, The findings of FAVOR III China were published in The Lacent（Impact...
Pulse Medical raises over $100M to improve precision pan-vascular interventional diagnostics
August 5, 2021
Shanghai Pulse Medical Technology, Inc.has raised more than $100 million in a series C funding...
OFR (World’s First OCT-Based FFR) Receives CE Mark!
April 26, 2020
OFR (World’s First OCT-Based FFR) Receives CE Mark! Pulse Medical (Pulse Medical Imaging...
Excellent Feedback from the 1st International Course on “Coronary Image Analysis and Computational Physiology”
July 5, 2019
Excellent Feedback from the 1st International Course on “Coronary Image Analysis and...
China FDA (NMPA) approval
July 26, 2018
China FDA (NMPA) approval In July 18th 2018, the official website of China Food and Drug...
PULSE - Leading the Precise Diagnosis and Treatment of Pan-vascular Intervention
Leading the Precise Diagnosis and Treatment of Pan-vascular Intervention